Please login to the form below

Not currently logged in
Email:
Password:

Bydureon

This page shows the latest Bydureon news and features for those working in and with pharma, biotech and healthcare.

AZ gets US green light for new Bydureon formulation

AZ gets US green light for new Bydureon formulation

AZ gets US green light for new Bydureon formulation. Its latest injectable suspension proven to reduce blood sugar levels. ... reduction. Ruud Dobber, president, AstraZeneca US, said: “With the approval of Bydureon BCise, we’re now introducing a new

Latest news

More from news
Approximately 2 fully matching, plus 55 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2016 Deal Watch October 2016

    150. AstraZeneca (UK). 3SBio. Distribution. Byetta, Bydureon (exanatide) for Type 2 diabetes in China.

  • Interview: Christopher Boulton, AstraZeneca Interview: Christopher Boulton, AstraZeneca

    This was then expanded in 2012 when the alliance acquired Amylin, gaining the rights to a portfolio of products for type 2 diabetes, including the exenatide franchise (Byetta and Bydureon).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics